The MDI Biological Laboratory has spun off the first company in its 115-year history, led by lab director Kevin Strange and regenerative biology researcher Voot Yin.

Strange told Mainebiz that the new company, Novo Biosciences Inc., will look at the therapeutic potential of drugs that speed tissue healing and stimulate the regeneration of lost and damaged body parts. Novo will start by studying an experimental drug that has been shown to double the regrowth rate of tissue after amputation using a zebrafish. The hope is that one day this work will translate to humans.

Read the rest of the article…